Neurocrine Biosciences Reports Second Quarter 2021 Financial Results
Go back to Neurocrine Biosciences Reports Second Quarter 2021 Financial Results| Neurocrine Biosciences, Inc. (NASDAQ: NBIX) | Delayed: 155.53 -1.23 (0.78%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $156.76 | 52 Week High | $58.46 | |||
| Open | $157.39 | 52 Week Low | $31.25 | |||
| Day High | $160.43 | P/E | N/A | |||
| Day Low | $155.09 | EPS | $-0.69 | |||
| Volume | 327,896 | |||||

